New tiny nasal spray launched in battle to overcome annual hayfever misery

March 24, 2011 - PRLog -- A TINY nasal spray which works faster than other treatments is set to help millions of people overcome their annual hayfever misery.
This year’s hayfever season (otherwise known as Seasonal Allergic Rhinitis) is expected to be worse than usual after the harsh winter delayed the release of pollen. Due to the freezing winter Birch pollen particles are not expected until after the usual April showers are replaced by warm, dry weather.
Three pollen seasons are now expected to merge into one onslaught, causing doctors to urge hayfever sufferers to stock up on medication to control the reaction to pollen.
Rhinolast Allergy, which is now available  for the first time over the counter as a 5ml nasal spray, starts working faster than many other anti-allergic therapies, relieving symptoms just  10- 15 minutes after application. In contrast, other treatments often start to act only after two or three hours. It costs £3.99.
It also means that, unlike other treatments, Rhinolast Allergy is effective even after the symptoms have appeared, avoiding the need to plan ahead of an expected allergen exposure.
Up to 16 million hayfever sufferers are only too familiar with the symptoms – watery rhinorrhoea, sneezing, itching of the mucosal lining, nasal obstruction and red and swollen eyes. The combination of these symptoms are not only irritating for sufferers but seriously debilitating, affecting work productivity, school performance, sleep patterns and leisure activities. Left untreated, the inflammation may develop into asthma. Rhinolast Allergy effectively targets all these symptoms within minutes.
Rhinolast Allergy is not a steroid treatment, however a comparison of the various treatment options showed Rhinolast Allergy to have a faster onset of action and better efficacy than the common steroid mometasone, while other research showed it to be as effective as the strongest corticosteroid fluticasone.
Other benefits to using Rhinolast Allergy include good tolerability, ease of use, long duration of action (Rhinolast Allergy is active for up to 12 hours) and reliability.
Rhinolast Allergy is also available as a POM in a 22ml size.

10 good reasons for prescribing Rhinolast Allergy:
1)   Triple mode of action: anti-inflammatory, mast-cell stabilizing and anti-histaminic
2)   For allergic rhinitis and accompanying conjunctivitis
3)   Relief of all symptoms
4)   Reliable, even in patients who are non-responders to oral anti-histamines
5)   Broad spectrum of application
6)   Fast onset of action
7)   Easy to use
8)   Once/twice daily dosing regime
9)   Use on an as-needed basis (prophylactically or symptomatically)
10)   Well-tolerated
www.meda.se

Editor’s notes
•   For more information, images or interviews please contact Lucy Mason at Mason Media on 0151 239 5050. Lucy@masonmedia.co.uk. Mobile : 07903 197402


About MEDA Pharmaceuticals Ltd
•   MEDA Pharmaceuticals Ltd is a leading international specialty pharma company. Meda’s products are sold in 120 countries worldwide and the company is represented by its own organizations in 50 countries. To find out more, visit www.meda.se

# # #

We are a communications consultancy which specialises in generating outstanding media coverage for our clients.
We pride ourselves on knowing the media inside out so have a total understanding of what it is that makes great column inches for them.